Read the full article by MIT about MBI HERE
|
|
|
|
|
|
|
|
|
|
|

MATCHPOINT: Has medulloblastoma met its match?

Duane Mitchell, MD, PhD, co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida, is leading the MATCHPOINT trial. The treatment uses adoptive cell therapy…

TRIALS APPROVED!

Drs. Duane Mitchell and Elias Sayour of the Cure Group 4 Consortium have received approval from the U.S. Food and Drug Administration (FDA) to test…

A milestone for MBI

Scientists, academics, researchers, businesspeople and media personalities met last Wednesday (10/04) at the Brazilian embassy in Washington…

In search of treatment for medulloblastoma

In March 2024, PUCRS Magazine published a beautiful interview given by alumnus Fernando Goldsztein, Founder of The Medulloblastoma Initiative and Advisor to the Children’s National Hospital Foundation…

A big step for MBI

On Wednesday, March 6, the story of the Medulloblastoma Initiative (MBI) was presented to the Permanent Council of the OAS (Organization of American States), in Washington D.C., during the session dedicated to World Rare Disease Day…